115 related articles for article (PubMed ID: 9755023)
1. Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat.
Khandwala H; Loomis CW
Pain; 1998 Jul; 77(1):87-95. PubMed ID: 9755023
[TBL] [Abstract][Full Text] [Related]
2. Comparable dose-dependent inhibition of AP-7 sensitive strychnine-induced allodynia and paw pinch-induced nociception by mexiletine in the rat.
Khandwala H; Hodge E; Loomis CW
Pain; 1997 Sep; 72(3):299-308. PubMed ID: 9313270
[TBL] [Abstract][Full Text] [Related]
3. Strychnine-dependent allodynia in the urethane-anesthetized rat is segmentally distributed and prevented by intrathecal glycine and betaine.
Sherman SE; Loomis CW
Can J Physiol Pharmacol; 1995 Dec; 73(12):1698-705. PubMed ID: 8834483
[TBL] [Abstract][Full Text] [Related]
4. Strychnine-sensitive modulation is selective for non-noxious somatosensory input in the spinal cord of the rat.
Sherman SE; Loomis CW
Pain; 1996 Aug; 66(2-3):321-30. PubMed ID: 8880856
[TBL] [Abstract][Full Text] [Related]
5. Coadministration of intrathecal strychnine and bicuculline effects synergistic allodynia in the rat: an isobolographic analysis.
Loomis CW; Khandwala H; Osmond G; Hefferan MP
J Pharmacol Exp Ther; 2001 Mar; 296(3):756-61. PubMed ID: 11181903
[TBL] [Abstract][Full Text] [Related]
6. Innocuous hair deflection evokes a nociceptive-like activation of catechol oxidation in the rat locus coeruleus following intrathecal strychnine: a biochemical index of allodynia using in vivo voltammetry.
Milne B; Duggan S; Jhamandas K; Loomis C
Brain Res; 1996 Apr; 718(1-2):198-202. PubMed ID: 8773787
[TBL] [Abstract][Full Text] [Related]
7. The glycine-prodrug, milacemide, increases the seizure threshold due to hyperbaric oxygen; prevention by 1-deprenyl.
Youdim MB; Kerem D; Duvdevani Y
Eur J Pharmacol; 1988 Jun; 150(3):381-4. PubMed ID: 3138141
[TBL] [Abstract][Full Text] [Related]
8. Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anesthetized rat.
Sherman SE; Loomis CW
Pain; 1994 Jan; 56(1):17-29. PubMed ID: 8159438
[TBL] [Abstract][Full Text] [Related]
9. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
[TBL] [Abstract][Full Text] [Related]
10. Microionophoretic study with milacemide, a glycine precursor, on mammalian central nervous system cells.
Godfraind JM
Br J Pharmacol; 1990 May; 100(1):119-25. PubMed ID: 2196964
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide.
Semba J; Curzon G; Patsalos PN
Br J Pharmacol; 1993 Apr; 108(4):1117-24. PubMed ID: 8485621
[TBL] [Abstract][Full Text] [Related]
12. Spinal strychnine alters response properties of nociceptive-specific neurons in rat medial thalamus.
Sherman SE; Luo L; Dostrovsky JO
J Neurophysiol; 1997 Aug; 78(2):628-37. PubMed ID: 9307100
[TBL] [Abstract][Full Text] [Related]
13. Modulation of vocal and nonvocal behavior in adult squirrel monkeys by selective MAO-A and MAO-B inhibition.
Newman JD; Winslow JT; Murphy DL
Brain Res; 1991 Jan; 538(1):24-8. PubMed ID: 1902133
[TBL] [Abstract][Full Text] [Related]
14. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
Janssens de Varebeke P; Pauwels G; Buyse C; David-Remacle M; De Mey J; Roba J; Youdim MB
J Neurochem; 1989 Oct; 53(4):1109-16. PubMed ID: 2769256
[TBL] [Abstract][Full Text] [Related]
15. The release of spinal prostaglandin E2 and the effect of nitric oxide synthetase inhibition during strychnine-induced allodynia.
Milne B; Hall SR; Sullivan ME; Loomis C
Anesth Analg; 2001 Sep; 93(3):728-33. PubMed ID: 11524348
[TBL] [Abstract][Full Text] [Related]
16. Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents.
Handelmann GE; Nevins ME; Mueller LL; Arnolde SM; Cordi AA
Pharmacol Biochem Behav; 1989 Dec; 34(4):823-8. PubMed ID: 2516327
[TBL] [Abstract][Full Text] [Related]
17. Spinal action of ketorolac, S(+)- and R(-)-ibuprofen on non-noxious activation of the catechol oxidation in the rat locus coeruleus: evidence for a central role of prostaglandins in the strychnine model of allodynia.
Hall SR; Milne B; Loomis C
Anesthesiology; 1999 Jan; 90(1):165-73. PubMed ID: 9915325
[TBL] [Abstract][Full Text] [Related]
18. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
O'Brien EM; Dostert P; Tipton KF
Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533
[TBL] [Abstract][Full Text] [Related]
19. MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice.
Colombo M; Strolin Benedetti M; Bonsignori A; Cocchiara G; Roncucci R; Dostert P
J Neural Transm Suppl; 1990; 32():123-9. PubMed ID: 2089081
[TBL] [Abstract][Full Text] [Related]
20. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?
Strolin Benedetti M; Cocchiara G; Colombo M; Dostert P
J Neural Transm Suppl; 1990; 32():351-6. PubMed ID: 2128509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
